Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
4.050
+0.040 (1.00%)
Oct 30, 2025, 4:00 PM EDT - Market closed
Precigen Revenue
Precigen had revenue of $856.00K in the quarter ending June 30, 2025, with 19.39% growth. This brings the company's revenue in the last twelve months to $4.34M, down -1.12% year-over-year. In the year 2024, Precigen had annual revenue of $3.93M, down -36.95%.
Revenue (ttm)
$4.34M
Revenue Growth
-1.12%
P/S Ratio
270.54
Revenue / Employee
$30,350
Employees
143
Market Cap
1.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.93M | -2.30M | -36.95% |
| Dec 31, 2023 | 6.23M | -20.68M | -76.87% |
| Dec 31, 2022 | 26.91M | 12.64M | 88.61% |
| Dec 31, 2021 | 14.27M | -17.73M | -55.40% |
| Dec 31, 2020 | 31.99M | -58.73M | -64.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PGEN News
- 17 days ago - Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis - PRNewsWire
- 2 months ago - Precigen Announces Up to $125 Million Non-Dilutive Financing - PRNewsWire
- 2 months ago - Precigen, Inc. - Special Call - Seeking Alpha
- 2 months ago - Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright - PRNewsWire
- 2 months ago - Undercovered Dozen: Precigen, ONEOK, Bitmine And More - Seeking Alpha
- 2 months ago - Precigen: This Billion-Dollar Approval Is Still Undervalued - Seeking Alpha
- 2 months ago - Why Is Precigen Stock Surging On Friday? - Benzinga
- 2 months ago - US FDA approves Precigen's immunotherapy for rare respiratory disease - Reuters